Eudaimonia Advisors’s Merck MRK Stock Holding History

Eudaimonia Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$1.63M	Buy	12,341 +113	+0.9%	+$13.9K	0.87%	32
2023 Q4	$1.33M	Sell	12,228 -996	-8%	-$103K	0.86%	32
2023 Q3	$1.36M	Sell	13,224 -891	-6%	-$96K	0.96%	30
2023 Q2	$1.63M	Sell	14,115 -94	-0.7%	-$10.7K	1.09%	23
2023 Q1	$1.51M	Sell	14,209 -374	-3%	-$40.4K	1.02%	25
2022 Q4	$1.62M	Buy	14,583 +1,989	+16%	+$203K	1.09%	21
2022 Q3	$1.08M	Sell	12,594 -195	-2%	-$17.4K	0.75%	36
2022 Q2	$1.17M	Buy	12,789 +4,955	+63%	+$439K	0.8%	31
2022 Q1	$643K	Buy	7,834 +414	+6%	+$32.6K	0.37%	78
2021 Q4	$569K	Buy	+7,420	New	+$591K	0.33%	84

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Eudaimonia Advisors's MRK Position: Q1 2024 in Review

Eudaimonia Advisors increased its Merck (MRK) stake by 0.92% in Q1 2024, buying an estimated $13.9K and bringing the position to 12,341 shares worth $1.63M. The position accounts for 0.87% of the portfolio, ranked #32.

Eudaimonia Advisors first reported a position in MRK in Q4 2021 and has held it in 10 quarters since. The position peaked at $1.63M in Q2 2023. 3,535 funds tracked by Wall St. Rank hold MRK as of Q1 2024.

Eudaimonia Advisors held 12,341 shares of Merck worth $1.63M as of Q1 2024.
Eudaimonia Advisors bought 113 Merck shares in Q1 2024, an estimated $13.9K.
Merck made up 0.87% of Eudaimonia Advisors's portfolio in Q1 2024, its #32 holding.
Eudaimonia Advisors first reported a position in Merck in Q4 2021 and has held it in 10 quarters since.
Eudaimonia Advisors's Merck position peaked at $1.63M in Q2 2023.
3,535 funds tracked by Wall St. Rank held Merck as of Q1 2024.

Based on Eudaimonia Advisors's 13F filing for Q1 2024, filed 25 Apr 2024.